Healthcare -
Biotechnology - NASDAQ - US
$ 2.42
-3.53 %
$ 6.17 M
Market Cap
-0.48
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Lipella Pharmaceuticals Inc.
| Revenue | 536 K |
| Cost Of Revenue | 3.61 M |
| Gross Profit | -3.08 M |
| Operating Expenses | 2 M |
| Operating Income | -5.08 M |
| Other Expenses | -64.3 K |
| Net Income | -5.02 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0.5 | 0.4 | 0.2 | 0.3 | 1.0 | 0.7 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 3.6 | 3.0 | 2.5 | 1.5 | 1.0 | 0.7 |
| Gross Profit | (3.1) | (2.6) | (2.4) | (1.2) | 14.3 K | 11.9 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 2.0 | 2.2 | 2.8 | 2.2 | 1.0 | 0.7 |
| Selling, General and Administrative Expenses | 2.0 | 2.2 | 0.2 | 0.7 | 42.6 K | 65.6 K |
| Research and Development Expenses | 0 | 3.0 | 2.5 | 1.5 | 1.0 | 0.7 |
| Operating Income | (5.1) | (4.7) | (2.6) | (1.9) | 56.9 K | 53.8 K |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 10.8 K | 9.61 K | 6.83 K | 7.96 K | 8.39 K |
| Total Other Income | 64.3 K | 0.1 | 7.98 K | 50.4 K | 4.79 K | 8.06 K |
| Pre-Tax Income | (5.0) | (4.6) | (2.6) | (1.9) | 61.7 K | 61.8 K |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | 1.63 K | 6.73 K | 4.79 K | 53.8 K |
| Net Income | (5.0) | (4.6) | (2.6) | (1.9) | 66.4 K | 61.8 K |
| EPS | 4.79 | 6.16 | 5.12 | 4.38 | 0.23 | 0.24 |